Cao Shui
Cao Shui — Chief Physician — Department of Biotherapy — Tianjin Medical University Cancer Hospital
Specialties
Lung cancer, malignant melanoma, urinary system tumors, gynecological tumors, digestive tract tumors, and sarcomas and other malignant tumors
Education
In July 1991, graduated with a bachelor's degree in Medicine from Tianjin Medical College. From 1996 to 2000, invited by Duke University in the United States, studied tumor immunology and biotherapy at its Cancer Medicine Center, mainly engaged in clinical, research, and teaching work in tumor biotherapy during this period. Published multiple academic papers. In April 2002, studied tumor gene therapy at Takara Medical Biotechnology Center in Japan. From 2007 to 2010, pursued a master's degree in Oncology at Tianjin Medical University while working.
Professional Experience
Male, Chief Physician of the Department of Tumor Biotherapy, currently serving as Deputy Director of the Department of Biotherapy at Tianjin Cancer Hospital, holds a Master's degree in Medicine, and is a postgraduate supervisor. He is proficient in the diagnosis and treatment of common tumors, mainly including lung cancer, malignant melanoma, urinary system tumors, gynecological tumors, digestive tract tumors, and sarcomas. Familiar with domestic and international developments in this field, he has conducted multiple new anti-tumor biotherapy techniques, carrying out comprehensive anti-tumor treatment based on biotherapy and chemotherapy. This includes CIK cell therapy for advanced renal cancer, DC tumor vaccine treatment for metastatic malignant melanoma, non-myeloablative allogeneic hematopoietic stem cell transplantation for high-risk breast cancer, NK cell therapy for advanced ovarian cancer, and specific GMV vaccine treatment for malignant tumors.
Professional Roles
Currently serves as a review expert for the General Program of the National Natural Science Foundation of China, a member of the Clinical Application Professional Committee of the China Medical Biotechnology Association, and a member of the Expert Group of the Tianjin Labor Ability Appraisal Committee. Member of the Clinical Application Professional Committee of the China Medical Biotechnology Association Standing member of the Clinical Committee of Biotherapy of the China Association of Research Hospitals Member of the Tianjin Chemotherapy Professional Committee of the Chinese Anti-Cancer Association Review expert of the National Natural Science Foundation of China Member of the Tianjin Labor Ability Appraisal Committee Expert of the Degree Evaluation Committee of the Ministry of Education